Identification |
Name: | 1,6-Naphthyridin-2(1H)-one,5,7-diethyl-3,4-dihydro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,hydrochloride (1:1) |
Synonyms: | 1,6-Naphthyridin-2(1H)-one,5,7-diethyl-3,4-dihydro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,monohydrochloride (9CI); ZD 7155 |
CAS: | 146709-78-6 |
Molecular Formula: | C26H26 N6 O . Cl H |
Molecular Weight: | 474.99 |
InChI: | InChI=1/C26H26N6O.ClH/c1-3-19-15-24-22(23(4-2)27-19)13-14-25(33)32(24)16-17-9-11-18(12-10-17)20-7-5-6-8-21(20)26-28-30-31-29-26;/h5-12,15H,3-4,13-14,16H2,1-2H3,(H,28,29,30,31);1H |
Molecular Structure: |
|
Properties |
Flash Point: | 405.2°C |
Boiling Point: | 746.4°Cat760mmHg |
Density: | g/cm3 |
Biological Activity: | A potent and selective competitive antagonist for the angiotensin II type 1 (AT 1 ) receptor. Displaces [ 125 I]-angiotensin II binding with an IC 50 value of 3.8 nM in guinea pig adrenal gland membranes. Orally active, and is more potent and longer-acting than the prototype AT 1 antagonist, losartan. |
Flash Point: | 405.2°C |
Safety Data |
|
|